HERMES MENDOZA-ZAVALA: Open Payments
NPI 1164964805 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,614 in 149 payments from 14 companies in 2025. Trend: 2023 $2,259 · 2024 $3,346 · 2025 $6,614
Food & beverage: $3,694Speaker / faculty: $2,803Education: $117
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $3,270 |
| Alkermes, Inc. | 19 | $458 |
| Teva Pharmaceuticals USA, Inc. | 18 | $457 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $440 |
| ABBVIE INC. | 11 | $378 |
| Collegium Pharmaceutical, Inc. | 13 | $340 |
| Neurocrine BioSciences, Inc. | 15 | $332 |
| Vanda Pharmaceuticals Inc. | 6 | $204 |
| Axsome Therapeutics, Inc. | 5 | $204 |
| Corium, LLC | 11 | $193 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Jornay PM, INGREZZA, ARISTADA, UZEDY, FANAPT.
Industry payments across TX — which companies pay providers there.
